Peter D. Suzdak
2016
In 2016, Peter D. Suzdak earned a total compensation of $824.1K as Chief Executive Officer at Rexahn Pharmaceuticals, a 23% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $150,500 |
|---|---|
| Option Awards | $229,581 |
| Salary | $430,000 |
| Other | $14,010 |
| Total | $824,091 |
Suzdak received $430K in salary, accounting for 52% of the total pay in 2016.
Suzdak also received $150.5K in non-equity incentive plan, $229.6K in option awards and $14K in other compensation.
Rankings
In 2016, Peter D. Suzdak's compensation ranked 9,165th out of 14,075 executives tracked by ExecPay. In other words, Suzdak earned more than 34.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,165 out of 14,075 | 35th |
Division Manufacturing | 3,542 out of 5,489 | 36th |
Major group Chemicals And Allied Products | 1,221 out of 1,895 | 36th |
Industry group Drugs | 968 out of 1,538 | 37th |
Industry Pharmaceutical Preparations | 770 out of 1,176 | 35th |
Source: SEC filing on February 24, 2017.
Suzdak's colleagues
We found three more compensation records of executives who worked with Peter D. Suzdak at Rexahn Pharmaceuticals in 2016.